I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| renal alpha-intercalated cell | 6 studies | 42% ± 12% | |
| basal cell | 6 studies | 29% ± 14% | |
| epithelial cell | 5 studies | 34% ± 10% | |
| endothelial cell | 4 studies | 20% ± 6% | |
| natural killer cell | 4 studies | 18% ± 3% | |
| fibroblast | 4 studies | 22% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| hematopoietic precursor cell | 3 studies | 20% ± 5% | |
| ciliated cell | 3 studies | 26% ± 1% | |
| erythroblast | 3 studies | 29% ± 9% | |
| GABAergic neuron | 3 studies | 35% ± 11% | |
| glutamatergic neuron | 3 studies | 39% ± 15% | |
| dendritic cell | 3 studies | 30% ± 4% | |
| astrocyte | 3 studies | 19% ± 2% |
